Treatment With 25-Hydroxyvitamin D(3) (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
25-羟基维生素D3（骨化二醇）治疗与COVID-19住院患者血液中性粒细胞与淋巴细胞比值（疾病严重程度标志物）降低相关：一项多中心、随机、安慰剂对照、双盲临床试验
期刊:Endocrine Practice
影响因子:4.6
doi:10.1016/j.eprac.2021.09.016
Maghbooli, Zhila; Sahraian, Mohammad Ali; Jamalimoghadamsiahkali, Saeidreza; Asadi, Asma; Zarei, Azadeh; Zendehdel, Abolfazl; Varzandi, Tarlan; Mohammadnabi, Sara; Alijani, Neda; Karimi, Mehrdad; Shirvani, Arash; Holick, Michael F
